Primary endpoint was not met in a study sponsored by Washington University; additional analyses are ongoing to understand the totality of the data Data from study in people with or at-risk for autosomal dominant Alzheimer’s disease will be presented at the AAT-AD/PD Focus meeting in April 2020 Results do not impact Roche’s two ongoing Phase... Read more
Workstations and high-content screening system automate workflows to help researchers generate invaluable insights WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today introduced new workstations and a high content screening system at SLAS2020 in San Diego (booth #929). These technologies automate workflows so that disease research and drug discovery professionals can... Read more
Basel, 24 January 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the Phase III IMvigor010 study evaluating Tecentriq® (atezolizumab) as an adjuvant (after surgery) monotherapy treatment did not meet its primary endpoint of disease-free survival (DFS) compared to observation in people with muscle-invasive urothelial cancer (MIUC). Safety for Tecentriq appeared consistent with... Read more
New Thermo Scientific NanoDrop QC Software Simplifies Sample Quality Control for Industrial Users Advanced features enable chemists to measure highly-concentrated samples without dilution HILLSBORO, Ore., Jan. 21, 2020 /PRNewswire/ — Thermo Fisher Scientific today released the Thermo Scientific NanoDrop QC Software for the Thermo Scientific NanoDrop OneC Spectrophotometer. Combined with the new software, the ultraviolet-visible... Read more
Germantown, Maryland; Hilden, Germany; and Saluggia, Italy, November 27, 2019 –QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced the U.S. launch of an automated workflow for QuantiFERON-TB Plus (QFT-Plus), the fourth-generation modern gold standard for latent tuberculosis (TB) detection, on DiaSorin’s LIAISON platforms. The U.S. Food and Drug Administration... Read more
Monday, 18 November 2019 09:00 Hits: 2833 ShareLinkedInTwitter Sephara is changing the way automated analytical sampling as well as perfusion processes at the benchtop scale will be performed Securecell offers an early access program for the Sephara technology URDORF (Zurich), Switzerland, November 18, 2019 / B3C newswire / — Securecell today announced that it has introduced Sephara, a high performance in-situ... Read more
Thermo Fisher Scientific Opens Customer Solution Center in China to Support Pharmaceutical and Biopharmaceutical Laboratories SHANGHAI, Nov. 13, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the official opening of a Customer Solution Center in Shanghai, China. This follows the recent announcements of a Biosciences Customer Exploration Center in Shanghai and... Read more
Hitachi High-Technologies Corporation (TSE:8036/Hitachi High-Tech) have undertaken a third-party allotment of shares (this capital alliance) with Vironova AB (Main office: Stockholm, Sweden /CEO: Mohammed Homman/Vironova), who develop and sell analysis software for transmission electron microscopes (TEM) along with carrying out contract analysis for pharmaceutical companies. Through this capital alliance, we aim to jointly develop TEM... Read more
GE Healthcare Life Sciences will supply Akeso Pharmaceuticals with the FlexFactory™ platform to accelerate the production of antibody drugs in the Guangzhou region Expected to be operational by end of 2020 and create up to 150 jobs upon opening. November 6, 2019 – Uppsala, Sweden and Guangzhou, China – Akeso Pharmaceuticals, a biotech company specializing... Read more